Evaluating a Pediatric Asthma Management Education Program for Physicians

NCT00399984 | Completed

• 2 other identifiers: 437R01HL070771
• Study Type: interventional
• Target: 40
• Locations: 1 country
• Sites: 1

Brief Summary

Inhaled corticosteroids taken on a daily basis have been proven to be the most effective treatment for children with persistent asthma. However, many pediatricians still do not prescribe daily corticosteroids to their asthmatic patients; this can lead to poor health outcomes among asthmatic children. This study will evaluate an interactive medical education program that focuses on improving pediatricians' asthma management skills and on encouraging increased corticosteroid use among their patients with asthma.

Conditions

Asthma; Education, Medical

Keywords

Continuing Medical Education

Outcome Measures

Primary Outcomes (2)

• Changes in physician knowledge, attitudes, and self-reported behavior

  1-3 years

• Changes in patient asthma outcomes (both measured on a yearly basis)

  1-3 years

Study Arms (2)

1

EXPERIMENTAL

Behavioral: Asthma Education Program

2

NO INTERVENTION

Interventions

Asthma Education Program BEHAVIORAL

interactive seminars regarding daily inhaled corticosteroids

1

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Pediatricians must meet all of the following criteria:
• Graduate of a pediatric residency program in the United States
• In active medical practice for at least 4 half-day sessions, with 40% clinical effort in general pediatrics
• At least 54 children with asthma in their patient population
• Parents of pediatric asthma patients must meet all of the following criteria:
• Parent or guardian of a pediatric patient that meets patient eligibility criteria
• Able to identify that the participating physician is the child's primary care pediatrician
• Provides most asthma management or is the adult who normally takes the child to the doctor
• Pediatric patients must meet all of the following criteria:
• Older than 4 years of age (to decrease the likelihood that the child has bronchiolitis)
• Younger than 16 years of age (to ensure that during all 3 years of the evaluation part of the study, the child will be younger than 20 years of age)
• Diagnosis of asthma made by a physician using commonly accepted clinical criteria
• No other chronic disorders that have pulmonary complications (e.g., sickle cell disease, tuberculosis, acquired immune deficiency syndrome \[AIDS\], cystic fibrosis)

Sponsors & Collaborators

• University of California, San Francisco: lead
• National Heart, Lung, and Blood Institute (NHLBI): collaborator

Study Sites (1)

University of California, San Francisco

San Francisco, California, 94118, United States

Location

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases

Study Officials

• Michael D. Cabana, MD, MPH

  University of California, San Francisco

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 13, 2006
• First Posted: November 15, 2006
• Study Start: April 1, 2004
• Primary Completion: June 1, 2009
• Study Completion: June 1, 2009
• Last Updated: June 13, 2013

Record last verified: 2013-06

Locations

US (1)